Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men

Human Reproduction

Volumn 14, Issue 6, 1999, Pages 1540-1545

  Liu, Peter Y ^a   Xirner, Leo T ^b   Rushford, Debra ^c   McDonald, Julian ^a   Baker, H W Gordon ^a   Conway, Ann J ^a   Handelsman, David J ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Gonadotrophin deficiency; HCG; Recombinant FSH; Spermatogenesis; Testis

Indexed keywords

CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BIRTH; CLINICAL ARTICLE; CLINICAL TRIAL; CORTICOTROPIN DEFICIENCY; DRUG EFFICACY; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG TOLERABILITY; HORMONE URINE LEVEL; HUMAN; INFERTILITY THERAPY; MALE; MALE INFERTILITY; MULTICENTER STUDY; ORGAN GROWTH; PREGNANCY; SPERMATOGENESIS; SPERMATOZOON COUNT; SPONTANEOUS ABORTION; SUBCUTANEOUS DRUG ADMINISTRATION; TESTIS SIZE;

EID: 0032991519     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.6.1540     Document Type: Article

References (50)

1. Anonymous (1995) Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Recombinant Human FSH Study Group. Fenil. Steril, 63,77-86.
2. Baker, H.W.G. (1994) Male infertility. In DeGroot, L.J. (ed.), Endocrinology. WB Saunders, Philadelphia, 3rd edn, pp. 2404-2433.
3. Burger, H.G. and Baker, H.W.G. (1984) Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism. Ann. N. Y. Acad. Sci., 438, 447-453.
4. Burgues, S., Calderon, M.D. and Spanish Group on Male Hypogonadotropic Hypogonadism (1997) Subcutaneous self-administration of highly purified follicle-stimulating hormone and human chorionic gonadotropin for treatment of male hypogonadotropic hypogonadism. Hum. Reprod., 12, 980-986.
5. Bums, A.S., Rodbard, H.W., Winters, S.J. et al. (1988) Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size. J. Clin. Endocrinol. Metab., 66, 1144-1151.
6. De Sanctis, V., Wonke, B., Vullo, C. etal. (1988) Induction of spermatogenesis in thalassaemia. Fertil. Steril., 50, 969-975.
7. Dierich, A., Sairam, M.R., Monaco, L. et al. (1998) Impairing follicle-stimulating hormone (FSH) signalling in-vivo: targetted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Nail Acad. Sci. USA, 95, 13612-13617.
8. European Metrodin HP Study Group (1998) Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. Fertil. Steril, 70, 256-262.
9. Finkel, D.M., Phillips, J.L. and Snyder, PJ. (1985) Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N. Engl. J. Med., 313, 651-655.
10. Gattuccio, F., D'AIia, O., Lo Bartolo, ô. et al (1984) Gonadotropic therapy in men with hypogonadotropic hypogonadism. J. Androi, 5, 106-110.
11. Gayral, M.N., Millet, D., Mandelbaum, J. et al. (1975) Hypogonadisme hypogonadtrope masculin. Ann. Endocrinol., 36, 227-241.
12. Gemzell, C. and Kjessler, B. (I964) Treatment of infertility after partial hypophysectomy with human gonadotrophins. Lancet, i, 644.
13. Gromoll, J., Simoni, M. and Nieschlag, E. (1996) An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J. Clin. Endocrinol. Metab 81, 1367-1370.
14. Handelsman, D.J., Turner, L., Boylan, L.M. et al. (1995) Pharmacokinetics of human follicle-stimulating hormone in gonadotropin-deficient men. J. Clin. Endocrinol. Metab., 80, 1657-63.
15. Handelsman, D.J., Conway, A.J., Howe, C.J. et al. (1996) Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot. J. Clin. Endocrinol. Metab., 81, 4113-4121.
16. Healy, D.L. and Evans, J. (1993) Creutzfeldt-Jakob disease after pituitary gonadotrophins. Br. Med. J., 307, 517-518.
17. Johnsen, S.G. (1978) Maintenance of spermatogenesis induced by HMG treatment by means of continuous HCG treatment in hypogonadotrophic men. Acta Endocrinol., 59, 763-769.
18. Jones, T.H. and Darne, J.E (1993) Self-administered subcutaneous human menopausal gonadotrophin for stimulation of testicular growth and the initiation of spermatogenesis in hypogonadotropic hypogonadism. Clin. Endocrinol. (O.rf.), 38, 203-208.
19. Kirk, J.M.W., Savage, M.O., Grant, D.B. et al. (1994) Gonadal function and response to human chorionic and menopausal gonadotrophin therapy in male patients with idiopathic hypogonadotrophic hypogonadism. Clin. Endocrinol. (Oxf.), 41, 57-63.
20. Kliesch, S., Behre, H.M. and Nieschlag, E. (1994) High efficacy of gonadotrophin or pusatile gonadotrophin-releasing hormone treatment in hypogonadotrophic hypogonadal men. Ear. J. Endocrinol., 131, 347-354.
21. Kliesch, S., Behre, H.M. and Nieschlag, E. (1995) Recombinant human follicle-stimulating hormone and human chorionic gonadotrophin for induction of spermatogenesis in a hypogonadotrophic male. Fertil. Steril., 63,1326-1328.
22. Kumar, T.R., Wang, Y., Lu, N. et al. (1997) FSH is required for ovarian follicle maturation but not for male fertility. Nature Genet., 15, 201-204.
23. Kung, A.W.C., Zhong, Y.Y., Lam, K.S.L. et al. (1994) Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotropic hypogonadism. Int. J. Androl., 17, 241-247.
24. le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. et al. (1994) Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. Fertil. Steril., 61, 669-678.
25. Ley, S.B. and Leonard, J.M. (1985) Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgen. J. Clin. Endocrinol. Metab., 61, 746-752.
26. Liu, L., Banks, S.M., Barnes, K.M. et al. (1988) Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab., 67, 1140-1145.
27. MacLeod, J., Pazianos, A. and Ray, B.S. (1964) Restoration of human spermatogenesis by menopausal gonadotrophins. Lancet, i, 1196.
28. Mannaerts, B., Fauser, B., Lahlou, N. et al. (1996) Serum hormone - concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadism. Fertil. Steril., 65, 406-410.
29. Mastrogiacomo, I., Motta, R.G., Botteon, S. et al. (1991) Achievement of spermatogenesis and genital tract maturation in hypogonadotropic hypogonadic subjects during long term treatment with gonadotropins or LHRH. Andrologia, 23, 285-289.
30. Matsumoto, A.M., Karpas, A.E. and Bremner, W.J. (1986) Chronic human chorionic gonadotropin administration in normal men: evidence that follicle stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. J. Clin. Endocrinol. Metab., 62,1184-1192.
31. Mattei, A. and Routier, R. (1978) Place du neopergonal dans le traitment des aimpuberismes hypogonadotropiques masculins. Semin. Hop. Paris, 54, 25-28.
32. McDonald, J.A., Handelsman, D.J., Dilworth, P. et al. (1993) Functional hypothalamo-pituitary adrenal insufficiency in non-alcoholic liver disease. J. Gastroenterol. Hepatol, 8, 247-253.
33. Okada, Y., Kondo, T., Okamoto, S. et al. (1992) Induction of ovulation and spermatogenesis by hMG/HCG in hypogonadotropic GH-deficient patients. Endocrinol. Japon., 39, 31-43.
34. Okuyama, A., Nakamura, M., Namiki, M. et al. (1986) Testicular responsiveness to long-term administration of hCG and hMG in patients with hypogonadotrophic hypogonadism. Harm. Res., 23, 21-30.
35. Phillip, M., Arbeite, J.E., Segev, Y. et al. (1998) Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N. Engl. J. Med., 338, 1729-1732.
36. Porchet, H.C., le Cotonnec, J. Y. and Loumaye, E. (1994) Clinical pharmacology of recombinant human follicle:stimulating hormone. III. Pharmacokineticpharmacodynamic modeling after repeated subcutaneous administration. Fertil. Steril., 61, 687-695.
37. Quinton, R., Matfin, G., Bouloux, P.M. et al. (1994) Successful induction of fertility in a hypogonadotropic male. Lancet, 343, 733.
38. Quinton, R., Bouloux, P.M., Illingworth, J.M. et al. (1996) Efficacy of recombinant follicle-stimulating hormone. Fertil. Steril., 66, 164.
39. Raivio, T., Toppari, J., Perheentupa, A. et al. (1997) Treatment of prepubertal gonadotrophin-deficient boys with recombinant human follicle-stimulating hormone [letter]. Lancet, 350, 263-264.
40. Saal, W., Happ, J., Cordes, U. et al. (1991) Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism. Fertil. Steril., 56, 319-324.
41. Schaison, G., Young, J., Pholsena, M. et al. (1993) Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab., 77, 1545-1549.
42. Schopohl, J., Eversmann, T., Mehltretter, G. et al. (1991) Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic.hypogonadism. Fertil. Steril., 56, 1143-1150.
43. Singh, J., O'Neill, C. and Handelsman, D.J. (1995) Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) mice. Endocrinology, 136, 5311-5321.
44. Tapanainen, J.S., Aittomaki, K., Min, J. et al. (1997) Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor present variable suppression of spermatogenesis and fertility. Nature Genet., 15, 205-206.
45. Vicari, E., Mongioi, A., Calogero, A.E. et al. (1992) Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism - long-term follow-up. Int. J. Androl., 15, 320-329.
46. WHO (1994) Annual Technical Report 1994. World Health Organization, Geneva.
47. WHO Task Force on Methods for the Regulation of Male Fertility (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet, 336, 955-959.
48. WHO Task Force on Methods for the Regulation of Male Fertility (1996) Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil. Steril., 65, 821-829.
49. World Health Organization (1992) WHO Laboratory Manual For The Examination of Human Semen and Sperm-Cervical Mucus Interaction. Cambridge University Press, Cambridge, 107 pp.
50. Zhengwei, Y., Wreford, N.G., Royce, P. et al. (1998) Stereological evaluation of human spermatogenesis after suppression by testosterone treatment: heterogeneous pattern of spermatogenic impairment. J. Clin. Endocrinol. Metab., 83, 1284-1291.